Implementation of a Pediatric-to-adult Asthma Transition Program
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01521247 |
Recruitment Status
:
Completed
First Posted
: January 30, 2012
Last Update Posted
: September 9, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Despite the clear and often stated need, a formal transition program does not exist for asthma patients as they move from pediatric to adult care in Western Canada. This population is not having their health care needs met. The investigators proposed study would evaluate a well structured transition program designed to facilitate continuity of care for this at risk patient population.
Primary hypothesis: A pediatric-to-adult asthma transition program will improve the asthma-specific quality of life of young asthma patients in the Calgary area over a 1 year period.
Secondary hypothesis: A pediatric-to-adult asthma transition program will improve asthma control, decrease asthma exacerbations, and reduce health care utilization in young asthma patients in the Calgary area over a 1 year period.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Asthma Education | Other: Asthma Transition Program | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Study Start Date : | April 2010 |
Actual Primary Completion Date : | July 2014 |
Actual Study Completion Date : | July 2015 |

Arm | Intervention/treatment |
---|---|
No Intervention: Control group
Usual care.
|
|
Asthma Transition Program
Asthma Transition Program
|
Other: Asthma Transition Program
Asthma Education.
Other Name: Asthma Education and Referral.
|
- Asthma Quality of Life Questionnaire with Standardized Activities [AQLQ(S)] [ Time Frame: 12 months ]AQLQ(S) will be recorded at baseline, 6 months, and 12 months. The primary outcome will be the change in AQLQ(S) from baseline to 12 months.
- Asthma Control Questionnaire (ACQ) [ Time Frame: 12 months ]The ACQ will be administered at baseline, 6 months, and 12 months. The secondary outcome will assess change in ACQ from baseline to 12 months.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 17 Years to 19 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- clinical diagnosis of asthma (as confirmed by a pediatric respirologist or pediatrician with asthma expertise, and including evidence of variable airflow obstruction, bronchial hyperresponsiveness, airway inflammation, and/or response to therapy)
Exclusion Criteria:
- patients who are known to be non-adherent within the Calgary Regional Pediatric Asthma Clinic (defined as >50% missed appointments over a 2 year period)
- patients unable to complete pulmonary function testing
- patients with a history of significant respiratory comorbid conditions (including history of cystic fibrosis, alpha-1 antitrypsin deficiency, and lung transplant - rhinosinusitis patients will not be excluded)
- patients unable to provide consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01521247
Canada, Alberta | |
Calgary Regional Pediatric Asthma Clinic | |
Calgary, Alberta, Canada, T3B 6A8 |
Study Director: | Mary Noseworthy, MD | Alberta Children's Hospital | |
Study Director: | Rodel Padua, RRT | ||
Study Director: | Sheldon Spier, MD | Alberta Children's Hospital | |
Study Director: | Ward Flemons, MD | University of Calgary | |
Principal Investigator: | Warren Davidson, MD | University of Calgary |
Responsible Party: | Warren Davidson, Principal Investigator, University of Calgary |
ClinicalTrials.gov Identifier: | NCT01521247 History of Changes |
Other Study ID Numbers: |
AJMG-2010 |
First Posted: | January 30, 2012 Key Record Dates |
Last Update Posted: | September 9, 2016 |
Last Verified: | September 2016 |
Keywords provided by Warren Davidson, University of Calgary:
Asthma Transition program Pediatric Adult |
Additional relevant MeSH terms:
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |